About this trial
The study aim to evaluate the relationship between some important hematologic indices in juvenile lupus erythematosus patients and if these indices may be use as markers of disease acitivity in these patients or not ,also evaluate the relationship with these markers and chronic organ damage index
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients who fillful 2012 SLICC criteria or 2019 ACR/EULAR criteria of systemic lupus erythematosus
Age of patients at disease onset before 18 years
Disqualifiers
Adult onset disease ( age at disease onset after 18 years
Any other chronic inflamatory disorders or other autoimmune diseases
Trial population
Patients males or females below age of 18 years diagnosed as juvenile systemic lupus erythematosus based on 2012 SLICC criteria or 2019 ACR/EULAR criteria
Trial design
Case-control
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Calculation of hematological indices in juvenile lupus erythematosus patients
Calculation of systemic inflamatory index,systemic information response index and aggregate index of systemic inflamation ,and correlate these indices to SLE disease activity index
Correlation between hematologic indices in juvenile lupus erythematosus patients and disease activity in these patients
SLEDAI score in juvenile lupus erythematosus patients
Secondary outcomes
Calculation of chronic damage index in juvenile lupus erythematosus patients
SLICC/ACR score in juvenile lupus erythematosus patients
Relationship between hematologic index and chronic organ damage index in juvenile lupus erythematosus patients
SLICC/ACR score
Sponsors and contacts
Click on the lead sponsor to view all of their trials.